Brought to you by:
Bryan Kay
Updated intermittent claudication guidelines reflect a decade of new evidence
The Society for Vascular Surgery (SVS) recently published comprehensive update to its clinical practice guidelines (CPGs) for the management of intermittent claudication (IC), urging clinicians to prioritize conservative treatment strategies and patient-centered care. The new recommendations, which appeared in the…
Enduring PROMISE: Real-world outcomes study suggests results continue to flow from transcatheter arterialization of the deep veins
First retrospective analysis shows comparable outcomes data to those found in PROMISE II pivotal trial, authors report. The first post-approval multicenter analysis of so-called “no-option” chronic limb-threatening ischemia (CLTI) patients treated using a pioneering transcatheter arterialization of the deep veins…
Eastern Vascular Society passes 1,000-member mark
It “takes village” to build a community like the one that the Eastern Vascular Society (EVS) has grown into, outgoing president Brajesh K. Lal, MD, told the EVS annual meeting in Nashville, Tennessee (Sept. 4–7). Lal was delivering the 2025…
Microbot Medical receives FDA 510(k) clearance for Liberty endovascular robotic system
Microbot Medical today announced that the Food and Drug Administration (FDA) has granted 510(k) clearance for the Liberty system, the first FDA cleared single use, remotely operated robotic system for peripheral endovascular procedures, states the company in a recent press…
Shape Memory Medical completes enrollment in EMBO-PMS registry
Shape Memory Medical today announced the completion of patient enrollment in the EMBO postmarket surveillance (EMBO-PMS) registry, the company’s prospective, multicenter registry of the Impede and Impede-FX embolisation plugs, and Impede-FX RapidFill device when used for peripheral vascular embolization. A…
EVS 2025: Eastern Vascular Society reveals 2025–26 officer class
Benjamin Jackson, MD, chief in the Division of Vascular and Endovascular Surgery at Lehigh Valley Heart and Vascular Institute in Allentown, Pennsylvania, became the new Eastern Vascular Society (EVS) president during the 2025 EVS annual meeting in Nashville (Sept. 4–7).…
Start of PAD Awareness Month heralds joint national effort to prevent amputations
The PAD Pulse Alliance—a coalition of leading medical societies that includes the Society for Vascular Surgery (SVS) dedicated to improving vascular health—is urging patients, providers and policymakers to act through its Get a Pulse on PAD Campaign as national PAD…
FDA begins ‘real-time’ reporting of adverse event data
The Food and Drug Administration (FDA) recently announced that it has begun daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS). The agency says that “this represents a significant step forward in modernizing the agency’s…
Boston Scientific recalls Carotid Wallstent Monorail devices over ‘manufacturing defect’
Boston Scientific has recalled its Carotid Wallstent Monorail endoprosthesis owing to a “manufacturing defect” that has led to devices having an inner lumen that is smaller than specifications, causing resistance when withdrawing the stent delivery system. A Food and Drug…
Pharmacologic treatment, follow-up in cessation services help drive abstinence in PAD patients
A recent French study suggests smoking cessation in patients with peripheral arterial disease (PAD) is achievable with intensive and appropriate management, with the prescription of a pharmacologic smoking cessation treatment and follow-up with smoking cessation services both identified as important…